 |
|
Vaccine Liability and Safety Revisited
Arch Pediatr Adolesc Med. 1998;152:7-10.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
IN THIS issue of the ARCHIVES, Zimmerman et al remind us that vaccine safety and liability issues remain close at hand, affecting immunization practice in various ambulatory primary care settings.1 Not only do vaccine-related litigation concerns continue, indicating a lack of awareness of the National Vaccine Injury Compensation Program (VICP), these concerns may be limiting our ability to achieve optimal childhood immunization coverage.
Figure appears in full text version.
|
|
|
|
|
The good news is . . . that there is good news. Liability protections instituted during the past 10 years have dramatically changed the litigious atmosphere surrounding immunization, and the safeguards in place today ensure the inherent safety of the products we routinely administer to our children. The recent change to the immunization schedule from oral poliovirus vaccine (OPV) to injected poliovirus vaccine (IPV) as the preferred choice, and the successful development and licensure of a new form of an acellular pertussis vaccine (DTaP) . . . [Full Text of this Article]
RELATED ARTICLE
Physician Concerns About Vaccine Adverse Effects and Potential Litigation
Richard Kent Zimmerman, James J. Schlesselman, Tammy A. Mieczkowski, Anne R. Medsger, and Mahlon Raymund
Arch Pediatr Adolesc Med. 1998;152(1):12-19.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Childhood Vaccine Risk/Benefit Communication in Private Practice Office Settings: A National Survey
Davis et al.
Pediatrics 2001;107:17e-17.
ABSTRACT
| FULL TEXT
No-Fault Vaccine Insurance: Lessons from the National Vaccine Injury Compensation Program
Ridgway
Journal of Health Politics, Policy and Law 1999;24:59-90.
ABSTRACT
|
